Journal Article

Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines

Huang, Qiaoxian, Yue, Ludan, Wang, Ruibing, Lee, Simon M. Y., Liu, Conghui, Wan, Jian-Bo, Gao, Cheng, Kwong, Cheryl H. T.

2020

Overview

Vascular disease remains the leading cause of death and disability, the etiology of which often involves atherosclerosis. The current treatment of atherosclerosis by pharmacotherapy has limited therapeutic efficacy. Here we report a biomimetic drug delivery system derived from macrophage membrane coated ROS-responsive nanoparticles (NPs). The macrophage membrane not only avoids the clearance of NPs from the reticuloendothelial system, but also leads NPs to the inflammatory tissues, where the ROS-responsiveness of NPs enables specific payload release. Moreover, the macrophage membrane sequesters proinflammatory cytokines to suppress local inflammation. The synergistic effects of pharmacotherapy and inflammatory cytokines sequestration from such a biomimetic drug delivery system lead to improved therapeutic efficacy in atherosclerosis. Comparison to macrophage internalized with ROS-responsive NPs, as a live-cell based drug delivery system for treatment of atherosclerosis, suggests that cell membrane coated drug delivery approach is likely more suitable for dealing with an inflammatory disease than the live-cell approach. Due to poor specificity, the current pharmacotherapy of atherosclerosis has limited therapeutic efficacy. Here, the authors show that a macrophage-biomimetic nanomedicine effectively alleviates atherosclerosis via targeted pharmacotherapy and sequestration of proinflammatory cytokines and chemokines.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 13 / 13/2 / 13/21 / 13/31 / 14 / 14/19 / 14/34 / 59 / 639/301/357 / 639/301/54 / 64/60 / Animals / Aorta - drug effects / Aorta - metabolism / Arteriosclerosis / Atherosclerosis / Atherosclerosis - drug therapy / Atherosclerosis - metabolism / Atorvastatin - therapeutic use / Biomimetic Materials / Biomimetics / Cell Membrane - metabolism / Cell membranes / Chemokines / Cytokines / Cytokines - metabolism / Drug delivery / Drug Delivery Systems / Drug Liberation / Drug therapy / Etiology / Female / Humanities and Social Sciences / Inflammatory diseases / Macrophages / Macrophages - metabolism / Membranes / Mice / multidisciplinary / Nanoparticles / Nanoparticles - metabolism / Nanotechnology / Pharmacology / RAW 264.7 Cells / Reactive Oxygen Species - metabolism / Reticuloendothelial system / Science / Science (multidisciplinary) / Synergistic effect / Treatment Outcome / Vascular diseases